Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Certain GLP-1s are approved to treat people with obesity and overweight and maybe at-risk for related conditions such as type 2 diabetes, high cholesterol, and high blood pressure
For semaglutide, microdosing might mean starting at 0.1 mg weekly instead of 0.25 mg, or staying at 0.25 mg for 8 weeks instead of 4 before escalating
To view or add a comment, sign in Very exciting news for Sophrosyne as we announce the formation of our Scientific Advisory Board
neither should those with a history of pancreatitis or gallbladder disease
What BMI threshold do they require
Theyre not waiting to get sick to seek treatment but are looking for ways to optimize their health now, or at least prevent the onset of chronic or age-related diseases as long as possible
